Castle Biosciences (CSTL) Cash & Equivalents Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Cash & Equivalents Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 70.63% |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn | -13.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.48% |
| Mar 31, 2026 | -17.80% |
| Dec 31, 2025 | -1.72% |
| Sep 30, 2025 | -13.93% |
| Jun 30, 2025 | -32.98% |
| Mar 31, 2025 | -33.79% |
| Dec 31, 2024 | -28.65% |
| Sep 30, 2024 | -36.05% |
| Jun 30, 2024 | -38.52% |
| Mar 31, 2024 | -41.15% |
| Dec 31, 2023 | -37.76% |
| Sep 30, 2023 | -20.72% |
| Jun 30, 2023 | -18.90% |
| Mar 31, 2023 | 5.19% |
| Dec 31, 2022 | 7.54% |
| Sep 30, 2022 | 12.40% |
| Jun 30, 2022 | 150.07% |
| Dec 31, 2021 | 319.07% |